Return to search

Palleon Pharmaceuticals lands $100m Series B

Palleon Pharmaceuticals, a biotech company, has closed $100 million in Series B financing.

Palleon Pharmaceuticals, a biotech company, has closed $100 million in Series B financing. Matrix Capital Management led the round with participation from SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, AbbVie Ventures and Surveyor Capital.

Source: Press Release